-
Mashup Score: 7New Developments in CAR T Treatments Webinar Infographic Series - 19 hour(s) ago
The following infographics are based on New Developments in CAR T Treatments Webinar Series, which aired on Tuesday, September 10, at 12 p.m. CDT and featured two presentations from Drs….
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 212025 Board of Directors Election Results - 2 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Please join us in welcoming our newly elected board members! These board members will begin their service to ASTCT after #Tandem25. Please join us in congratulating our new officers! Learn more about our incoming board members here: https://t.co/DIl9TyXJqq https://t.co/MU2lmymTXJ
-
-
Mashup Score: 4Translational Science Training Course - 4 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 4Regulation of CAR T cell exhaustion and effects of IL-4 - 4 day(s) ago
Stewart CM, Siegler EL, Sakemura RL, et al. IL-4 Drives Exhaustion of CD8-Positive CART Cells. Nature Communications. 2024; (doi: 10.1038/s41467-024-51978-3). Researchers say interleukin 4…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers say interleukin 4 (IL-4) is implicated in chimeric antigen receptor (CAR) T-cell exhaustion — a primary factor blocking durable response to CAR immunotherapy — and thus may represent a pathway to improved efficacy. Read more on Nucleus: https://t.co/lsHDnvtavK https://t.co/eZXhnNhzKd
-
-
Mashup Score: 21Combinatorial use of bridging molecules with AdCAR T-cells targeting AML to eliminate tumor cells - 7 day(s) ago
Volta L, Myburgh R, Pellegrino C, et al. Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia With CAR T-Cells. Leukemia. 2024; (doi:…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Adaptor chimeric antigen receptor (AdCAR) T-cell platforms may allow for better immune-targeting of acute myeloid leukemia (AML), according to researchers. Read more on Nucleus: https://t.co/ye9zjnR7kE https://t.co/4HI1IeZHKH
-
-
Mashup Score: 2
Tix T, Alhomoud M, Shouval R, et al. Second Primary Malignancies After CAR T-Cell Therapy: A Systematic Review and Meta-Analysis of 5,517 Lymphoma and Myeloma Patients. Clinical Cancer Research….
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Findings from the Phase 3 AURIGA trial support the use of lenalidomide plus daratumumab (D-R) over lenalidomide alone (R) as post-transplant maintenance therapy for patients with newly diagnosed multiple myeloma. Read more on Nucleus: https://t.co/U6YKE5M7yb https://t.co/UykAMnLIJl
-
-
Mashup Score: 0
Researchers at SickKids Hospital and McMaster University have developed a novel chimeric antigen receptor (CAR) T-cell therapy targeting ROBO1, a protein involved in axonal guidance, for the…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers @SickKidsNews and @machealthsci have developed a novel chimeric antigen receptor #CARTcell therapy targeting ROBO1, a protein involved in axonal guidance, for the treatment of recurrent glioblastoma (rGBM). Read more: https://t.co/JONng8m4lu https://t.co/X4ZjfLA5uo
-
-
Mashup Score: 1Become a Member Today - 15 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
For a limited time, join ASTCT now and become a member through 2025 with our extended membership option! Learn more about the benefits of an ASTCT membership and join now: https://t.co/amWRieR9H6 https://t.co/avnoyV1gUN
-
-
Mashup Score: 0Combining CAR T-cell therapy with cytokine signaling blockers to boost outcomes in AML - 16 day(s) ago
Bhagwat AS, Torres L, Shestova O, et al. Cytokine-Mediated CAR T Therapy Resistance in AML. Nature Medicine. 2024; (doi: 10.1038/s41591-024-03271-5). Researchers report that while autologous…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers report that while autologous #CARTcell therapy manufacturing is possible in the setting of #AML, myeloid-supporting cytokines released during CAR-T treatment affect efficacy. Read more: https://t.co/AP64OTGiX5 https://t.co/W11fZK5uPZ
-
-
Mashup Score: 3Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach - 16 day(s) ago
Welcome to the first installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US. In this series, ASTCT President Dr. Corey Cutler speaks with authors…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
In this special ep. of the podcast, ASTCT President Dr. Corey Cutler speaks with Dr. Katie Luo, a leading ophthalmologist to discuss ocular cGVHD. Thanks to Sanofi US for their support via an educational grant. Listen now: https://t.co/Ig61yJhX2y https://t.co/bsVQnfRoCU
-
Created with content from our New Developments in CAR T webinar series, this infographic features key info about recharging NK cells for cancer therapy. View the full series of infographics: https://t.co/hiDdTMByGe https://t.co/KxgAk8KhfF